361 related articles for article (PubMed ID: 10443662)
1. Antimüllerian hormone in patients with hypogonadotropic hypogonadism.
Young J; Rey R; Couzinet B; Chanson P; Josso N; Schaison G
J Clin Endocrinol Metab; 1999 Aug; 84(8):2696-9. PubMed ID: 10443662
[TBL] [Abstract][Full Text] [Related]
2. Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans.
Young J; Rey R; Schaison G; Chanson P
Mol Cell Endocrinol; 2003 Dec; 211(1-2):51-4. PubMed ID: 14656476
[TBL] [Abstract][Full Text] [Related]
3. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R
J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161
[TBL] [Abstract][Full Text] [Related]
4. Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development.
Rey R; Lordereau-Richard I; Carel JC; Barbet P; Cate RL; Roger M; Chaussain JL; Josso N
J Clin Endocrinol Metab; 1993 Nov; 77(5):1220-6. PubMed ID: 8077315
[TBL] [Abstract][Full Text] [Related]
5. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
6. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
[TBL] [Abstract][Full Text] [Related]
7. [Anti-Müllerian hormone (AMH) measurements in the assessment of testicular function in prepubertal boys and in sexual differentiation disorders].
Szarras-Czapnik M; Gajewska M; Ksiazyk J; Janas R; Ginalska-Malinowska M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):195-9. PubMed ID: 17020655
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement.
Rey RA; Belville C; Nihoul-Fékété C; Michel-Calemard L; Forest MG; Lahlou N; Jaubert F; Mowszowicz I; David M; Saka N; Bouvattier C; Bertrand AM; Lecointre C; Soskin S; Cabrol S; Crosnier H; Léger J; Lortat-Jacob S; Nicolino M; Rabl W; Toledo SP; Baş F; Gompel A; Czernichow P; Josso N
J Clin Endocrinol Metab; 1999 Feb; 84(2):627-31. PubMed ID: 10022428
[TBL] [Abstract][Full Text] [Related]
9. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
Trabado S; Maione L; Bry-Gauillard H; Affres H; Salenave S; Sarfati J; Bouvattier C; Delemer B; Chanson P; Le Bouc Y; Brailly-Tabard S; Young J
J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640
[TBL] [Abstract][Full Text] [Related]
11. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
Wang C; Tso SC; Todd D
J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
[TBL] [Abstract][Full Text] [Related]
12. Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.
Hero M; Tommiska J; Vaaralahti K; Laitinen EM; Sipilä I; Puhakka L; Dunkel L; Raivio T
Fertil Steril; 2012 May; 97(5):1242-7. PubMed ID: 22405597
[TBL] [Abstract][Full Text] [Related]
13. Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse.
Al-Attar L; Noël K; Dutertre M; Belville C; Forest MG; Burgoyne PS; Josso N; Rey R
J Clin Invest; 1997 Sep; 100(6):1335-43. PubMed ID: 9294098
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of serum inhibin concentrations by gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism.
Sheckter CB; McLachlan RI; Tenover JS; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1221-4. PubMed ID: 3142917
[TBL] [Abstract][Full Text] [Related]
15. Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency.
Luboshitzky R; Lavi S; Thuma I; Lavie P
J Clin Endocrinol Metab; 1996 Feb; 81(2):770-4. PubMed ID: 8636302
[TBL] [Abstract][Full Text] [Related]
16. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
[TBL] [Abstract][Full Text] [Related]
17. [Antimullerian hormone in clinical human applications].
Josso N; Rey R
Contracept Fertil Sex; 1994 Oct; 22(10):661-3. PubMed ID: 7804385
[TBL] [Abstract][Full Text] [Related]
18. The concordance between serum anti-Mullerian hormone and testosterone concentrations depends on duration of hCG stimulation in boys undergoing investigation of gonadal function.
Ahmed SF; Keir L; McNeilly J; Galloway P; O'Toole S; Wallace AM
Clin Endocrinol (Oxf); 2010 Jun; 72(6):814-9. PubMed ID: 19811508
[TBL] [Abstract][Full Text] [Related]
19. Daytime plasma melatonin levels in male hypogonadism.
Ozata M; Bulur M; Bingol N; Beyhan Z; Corakci A; Bolu E; Gundogan MA
J Clin Endocrinol Metab; 1996 May; 81(5):1877-81. PubMed ID: 8626851
[TBL] [Abstract][Full Text] [Related]
20. Single versus repeated dose human chorionic gonadotropin stimulation in the differential diagnosis of hypogonadotropic hypogonadism.
Dunkel L; Perheentupa J; Sorva R
J Clin Endocrinol Metab; 1985 Feb; 60(2):333-7. PubMed ID: 3965492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
